Patients buying the vials have to source their own syringes ... copycat versions within the next few weeks. Companies like Hims & Hers and WeightWatchers have been providing compounded versions ...
For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Citing third-party data, Hettenback said downloads of the Hims & Hers apps increased 47% year over year in February. What it means for Hims & Hers stock. On Apple's App Store, Him ...
The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...
Telehealth company Hims & Hers (HIMS) saw a major boost in app downloads during February. According to a Top-rated analyst, Craig ...
SAN FRANCISCO, February 24, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth ...
In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other stocks that outperform the broader market. Imagine choosing a group of stocks that ...
Investing.com -- Shares of Hims and Hers (NYSE:HIMS) fell 3% amidst news of Novo Nordisk (NYSE:NVO) introducing NovoCare Pharmacy, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback